Arrowstreet Capital’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $6.14M | Buy |
|
|||||
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $9.11M | Sell |
|
|||||
|
2024
Q1 | $14.3M | Buy |
|
|||||
|
2023
Q4 | $13.5M | Sell |
|
|||||
|
2023
Q3 | $21.1M | Sell |
|
|||||
|
2023
Q2 | $57.1M | Buy |
|
|||||
|
2023
Q1 | $54.7M | Buy |
|
|||||
|
2022
Q4 | $49.3M | Buy |
|
|||||
|
2022
Q3 | $12.8M | Buy |
|
|||||
|
2022
Q2 | $2.19M | Buy |
|
|||||
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $4.36M | Buy |
|
|||||
|
2020
Q4 | $276K | Sell |
|
|||||
|
2020
Q3 | $14.3M | Sell |
|
|||||
|
2020
Q2 | $18.5M | Buy |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $2.15M | Sell |
|
|||||
|
2019
Q1 | $2.15M | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $21.5M | Sell |
|
|||||
|
2018
Q2 | $39.4M | Buy |
|
|||||
|
2018
Q1 | $6.14M | Buy |
|
|||||
|
2017
Q4 | – | Sell |
|
|||||
|
2017
Q3 | $6.95M | Buy |
|
|||||
|
2017
Q2 | $6.12M | Buy |
|
|||||
|
2016
Q2 | – | Sell |
|
|||||
|
2016
Q1 | $378K | Sell |
|
|||||
|
2015
Q4 | $4.04M | Buy |
|
|||||
|
2015
Q3 | $3.02M | Buy |
|
|||||
|
2015
Q2 | $343K | Buy |
|
|||||
|
2014
Q4 | – | Sell |
|
|||||
|
2014
Q3 | $709K | Buy |
|
|||||
|
2014
Q2 | – | Sell |
|
|||||
|
2014
Q1 | $3.63M | Buy |
|